Related Experiment Video

Updated: May 4, 2026

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

6.8K

The regulation of MDM2 oncogene and its impact on human cancers

Yuhan Zhao1, Haiyang Yu, Wenwei Hu

  • 1Rutgers Cancer Institute of New Jersey, Rutgers the State University of New Jersey, New Brunswick, NJ 08903, USA.

Acta Biochimica Et Biophysica Sinica
|January 7, 2014
PubMed

Insights

The tumor suppressor p53 is regulated by MDM2, a key protein in cancer. Understanding MDM2 regulation is crucial for developing new cancer therapies targeting p53.

Area of Science:

  • Molecular Biology
  • Oncology
  • Biochemistry

Background:

  • The tumor suppressor p53 is vital for preventing cancer formation.
  • MDM2 (Murine double minute 2) is an E3 ubiquitin ligase and a critical negative regulator of p53.
  • MDM2 forms an auto-regulatory feedback loop with p53 and functions as an oncogene.

Purpose of the Study:

  • To provide an overview of the regulation of MDM2.
  • To highlight the impact of MDM2 dysregulation on p53 function and tumorigenesis.
  • To emphasize the potential of targeting MDM2 for cancer therapy.

Main Methods:

  • This review synthesizes existing research on MDM2 regulation.
  • It examines transcriptional, translational, and post-translational regulatory mechanisms of MDM2.
  • The oncogenic activities of MDM2 are discussed.

Main Results:

  • MDM2 levels and activity are tightly controlled through multiple regulatory layers.
  • Increased MDM2 expression is observed in various human cancers.
  • Dysregulation of MDM2 significantly affects p53 activity and promotes tumorigenesis.

Conclusions:

  • A comprehensive understanding of MDM2 regulation is essential for developing effective cancer therapeutics.
  • Targeting MDM2 to reactivate p53 holds promise for novel cancer treatment strategies.
Keywords:
E3 ubiquitin ligaseMDM2gene regulationp53

More Related Videos

Focus Formation: A Cell-based Assay to Determine the Oncogenic Potential of a Gene08:18

Focus Formation: A Cell-based Assay to Determine the Oncogenic Potential of a Gene

Published on: December 31, 2014

27.7K
Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors06:07

Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors

Published on: August 5, 2022

2.5K

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.3K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
3.5K
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
28.7K
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
6.1K